Traumatic brain injury: pathogenesis, experimental models, prospects of cell-based therapy

Cell and Organ Transplantology. 2017; 5(2):209-215.
DOI: 10.22494/COT.V5I2.78

Traumatic brain injury: pathogenesis, experimental models, prospects of cell-based therapy

Chayka A. V.¹, Zaben’ko Y. Y.¹, Labunets I. F.², Pivneva T. A.^1,2¹Bogomoletz Institute of Physiology National Academy of Sciences of Ukraine, Kyiv, Ukraine
²State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

Abstract
Traumatic brain injury is the brain damage caused by external mechanical force, for example: a severe impact as a result of a car accident, a blow of a blast wave, biomechanical damage to the brain as a result of a collision with contact sports, etc. This is a complex trauma with a wide range of symptoms became the main cause of death and disability in modern society throughout the world. The results of numerous therapeutic approaches to treating the consequences of injuries have shown promising perspectives in animal models of traumatic brain injury, but have not achieved any significant efficacy in clinical trials. In this review, we will consider the current topical issues of traumatic brain injury: a modern classification; general principles of the development of the pathological process; models of brain trauma in animals; therapy with the application of stem cells of various genesis.

Key words: traumatic brain injury; animal models of traumatic brain injury; stem cells therapy

Full Text PDF (eng) Full Text PDF (ru)

References

1. Menon DK, Schwab K, Wright DW, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010; 91(11): 1637-40. https://doi.org/10.1016/j.apmr.2010.05.017 PMid:21044706

2. Saatman KE, Duhaime AC, Bullock R, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008; 25(7): 719-38. https://doi.org/10.1089/neu.2008.0586 PMid:18627252 PMCid:PMC2721779

3. Rostami E. Traumatic Brain Injury Models in Animals. Methods Mol Biol. 2016; 1462: 47-59. https://doi.org/10.1007/978-1-4939-3816-2_4 PMid:27604712

4. Prins M, Greco T, Alexander D, et al. The pathophysiology of traumatic brain injury at a glance. Dis Model Mech. 2013; 6(6): 1307-15. https://doi.org/10.1242/dmm.011585 PMid:24046353 PMCid:PMC3820255

5. Faul M, Xu L, Wald MM, et al. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. 2010. Available: https://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf https://doi.org/10.15620/cdc.5571

7. Ovsyannikov DM, Chekhonatsky AA, Kolesov VN, et al. Social and Epidemiological Aspects of Craniocerebral Trauma (review). Saratov Journal of Medical Scientific Research. 2012; 8(3): 777–85.

8. Agoston DV. Bench-to-Bedside and Bedside Back to the Bench; Seeking a Better Understanding of the Acute Pathophysiological Process in Severe Traumatic Brain Injury. Front Neurol. 2015; 6: 47 https://doi.org/10.3389/fneur.2015.00047 PMid:25852631 PMCid:PMC4362297

9. Blyth BJ, Bazarian JJ. Traumatic alterations in consciousness: traumatic brain injury. Emerg Med Clin North Am. 2010; 28(3): 571-94. https://doi.org/10.1016/j.emc.2010.03.003 PMid:20709244 PMCid:PMC2923650

10. Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010; 27(8): 1529-40. https://doi.org/10.1089/neu.2010.1358 PMid:20504161

11. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007; 99(1): 4-9. https://doi.org/10.1093/bja/aem131 PMid:17573392

12. Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013; 14(2): 128-42. https://doi.org/10.1038/nrn3407 PMid:23329160 PMCid:PMC3951995

13. Reilly PL, Graham DI, Adams JH, et al. Patients with head injury who talk and die. Lancet 2. 1975; 7931: 375-7. https://doi.org/10.1016/S0140-6736(75)92893-7

14. Algattas H, Huang JH. Traumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injury. Int J Mol Sci. 2014; 15(1): 309-41. https://doi.org/10.3390/ijms15010309 PMid:24381049 PMCid:PMC3907812

15. Jalloh I, Carpenter KL, Helmy A, et al. Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings. Metab Brain Dis. 2015; 30(3): 615-32. https://doi.org/10.1007/s11011-014-9628-y PMid:25413449 PMCid:PMC4555200

16. Hinzman JM, Thomas TC, Quintero JE, et al. Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury. J Neurotrauma. 2012; 29(6): 1197-208. https://doi.org/10.1089/neu.2011.2261 PMid:22233432 PMCid:PMC3325551

17. Xiong Y, Gu Q, Peterson PL, et al. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma. 1997; 14(1): 23-34. https://doi.org/10.1089/neu.1997.14.23 PMid:9048308

18. Farkas O, Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res. 2007; 161: 43-59. https://doi.org/10.1016/S0079-6123(06)61004-2

19. Tomkins O, Feintuch A, Benifla M, et al. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol. 2011; doi:10.1155/2011/765923. https://doi.org/10.1155/2011/765923

20. Stoica BA, Faden AI. Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics. 2010; 7(1): 3-12. https://doi.org/10.1016/j.nurt.2009.10.023 PMid:20129492 PMCid:PMC2841970

21. Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015; 72(3): 355-62. https://doi.org/10.1001/jamaneurol.2014.3558 PMid:25599342 PMCid:PMC5001842

22. Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev. 2011; 91(2): 461-553. https://doi.org/10.1152/physrev.00011.2010 PMid:21527731

23. Mannix R, Berglass J, Berkner J, et al. Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injury. 2014; 12(6): 1342-50.

24. Hanisch UK, van Rossum D, Xie Y, et al. The microglia-activating potential of thrombin: the protease is not involved in the induction of proinflammatory cytokines and chemokines. J Biol Chem. 2004; 279(50): 51880-7. https://doi.org/10.1074/jbc.M408318200 PMid:15452111

25. Zabenko YY, Pivneva TA. Flavonoid quercetin reduces gliosis after repetitive mild traumatic brain injury in mice. Fisiol Zh. 2016; 62(5): 50-6. https://doi.org/10.15407/fz62.05.050

26. Wurzelmann M, Romeika J, Sun D. Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury. Neural Regen Res. 2017; 12(1): 7-12. https://doi.org/10.4103/1673-5374.198964 PMid:28250730 PMCid:PMC5319242

27. Loane DJ, Kumar A. Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol. 2016; 275(3): 316-27. https://doi.org/10.1016/j.expneurol.2015.08.018 PMid:26342753 PMCid:PMC4689601

28. Iudice A, Murri L. Pharmacological prophylaxis of post-traumatic epilepsy. Drugs. 2000; 59(5): 1091-9. https://doi.org/10.2165/00003495-200059050-00005 PMid:10852641

29. Dixon CE, Lyeth BG, Povlishock JT, et al. A fluid percussion model of experimental brain injury in the rat. J Neurosurg. 1987; 67(1): 110-9. https://doi.org/10.3171/jns.1987.67.1.0110 PMid:3598659

30. Finnie JW, Blumbergs PC. Animal models. Traumatic brain injury. Vet Pathol. 2002; 396: 679-689. https://doi.org/10.1354/vp.39-6-679 PMid:12450198

31. Morales DM, Marklund N, Lebold DD, et al. Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? Neuroscience. 2005;136(4): 971-89. https://doi.org/10.1016/j.neuroscience.2005.08.030 PMid:16242846

32. Zabenko Ye, Pivneva T. Behavioral reactions and structural alterations of hippocampal tissue after repetitive mild traumatic brain injury in mice. Studia Universitatis Babeş – Bolyai, Biologia, Lix. 2014; 2: 63-71.

33. Marmarou A, Foda MA, van den Brink W, et al. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg. 1994; 80(2): 291-300. https://doi.org/10.3171/jns.1994.80.2.0291 PMid:8283269

34. Lighthall JW. Controlled cortical impact: a new experimental brain injury model. J Neurotrauma. 1988; 5: 1-15. https://doi.org/10.1089/neu.1988.5.1 PMid:3193461

35. Dixon CE, Clifton GL, Lighthall JW, et al. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods. 1991; 39(3): 253-62. https://doi.org/10.1016/0165-0270(91)90104-8

36. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma. 2002; 19(5): 503-557. https://doi.org/10.1089/089771502753754037 PMid:12042091 PMCid:PMC1462953

37. Gurkoff G, Shahlaie K, Lyeth B, et al. Voltage-gated calcium channel antagonists and traumatic brain injury. Pharmaceuticals (Basel). 2013; 6(7): 788-812. https://doi.org/10.3390/ph6070788 PMid:24276315 PMCid:PMC3816709

38. Hall ED, Vaishnav RA, Mustafa AG. Antioxidant therapies for traumatic brain injury. Neurotherapeutics. 2010; 7(1): 51-61. https://doi.org/10.1016/j.nurt.2009.10.021 PMid:20129497 PMCid:PMC2818465

39. Gudeman SK, Miller JD, Becker DP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg. 1979; 51(3): 301-306. https://doi.org/10.3171/jns.1979.51.3.0301 PMid:469578

40. Morris GF, Bullock R, Marshall SB, et al. Failure of the competitive N-Methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg. 1999; 91(5): 737-43. https://doi.org/10.3171/jns.1999.91.5.0737 PMid:10541229

41. Ahmed AI, Gajavelli S, Spurlock MS, et al. Stem cells for therapy in TBI. J R Army Med Corps. 2016; 162(2): 98-102. https://doi.org/10.1136/jramc-2015-000475 PMid:26338987

42. Arsenijevic Y, Villemure JG, Brunet JF, et al. Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol. 2001; 170(1): 48-62. https://doi.org/10.1006/exnr.2001.7691 PMid:11421583

43. Cameron HA, McKay RD. Restoring production of hippocampal neurons in old age. Nat Neurosci. 1999; 2(10): 894-7. https://doi.org/10.1038/13197 PMid:10491610

44. Sun D. The potential of endogenous neurogenesis for brain repair and regeneration following traumatic brain injury. Neural Regeneration Research. 2014; 9(7): 688-92. https://doi.org/10.4103/1673-5374.131567 PMid:25206873 PMCid:PMC4146269

45. van Praag H, Schinder AF, Christie BR. Functional neurogenesis in the adult hippocampus. Nature. 2002; 415(6875): 1030-4. https://doi.org/10.1038/4151030a PMid:11875571

46. Dixon KJ, Theus MH, Nelersa CM, et al. Endogenous neural stem/progenitor cells stabilize the cortical microenvironment after traumatic brain injury. J Neurotrauma. 2015; 32(11): 753-64. https://doi.org/10.1089/neu.2014.3390 PMid:25290253 PMCid:PMC4449704

47. Rolfe A, Sun D. Stem Cell Therapy in Brain Trauma: Implications for Repair and Regeneration of Injured Brain in Experimental TBI Models. CRC Press/Taylor & Francis (c) 2015. 200p.

48. Zheng W, ZhuGe Q, Zhong M, et al. Neurogenesis in adult human brain after traumatic brain injury. J Neurotrauma. 2013; 30(22): 1872-80. https://doi.org/10.1089/neu.2010.1579 PMid:21275797 PMCid:PMC3815038

49. Sun D, Bullock MR, Altememi N, et al. The effect of epidermal growth factor in the injured brain after trauma in rats. J Neurotrauma. 2010; 27(5): 923-38. https://doi.org/10.1089/neu.2009.1209 PMid:20158379 PMCid:PMC2943945

50. Llorens-Bobadilla E, Zhao S, Baser A, et al. Single-cell transcriptomics reveals a population of dormant neural stem cells that become activated upon brain injury. Cell Stem Cell. 2015; 17(3): 329-40. https://doi.org/10.1016/j.stem.2015.07.002 PMid:26235341

51. Goodus MT, Guzman AM, Calderon F, et al. Neural stem cells in the immature, but not the mature, subventricular zone respond robustly to traumatic brain injury. Dev Neurosci. 2015; 37(1): 29-42. https://doi.org/10.1159/000367784 PMid:25377490

52. Koch P, Kokaia Z, Lindvall O, et al. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol. 2009; 8(9): 819-29. https://doi.org/10.1016/S1474-4422(09)70202-9

53. van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. 1999; 2(3): 266-70. https://doi.org/10.1038/6368 PMid:10195220

54. Dadwal P, Mahmud N, Sinai L, et al. Activating еndogenous neural precursor cells using metformin leads to neural repair and functional recovery in a model of childhood brain injury. Stem Cell Reports. 2015; 5(2): 166-73. https://doi.org/10.1016/j.stemcr.2015.06.011 PMid:26235894 PMCid:PMC4618663

55. Tsymbaliuk VI, Medvediev VV. Neyrogennye stvolovye kletki [Neurogenic stem cells]. Kiev: Koval, 2005. 596 p. [In Russian] PMid:16108229

56. Donega М, Giusto E, Cossetti C, et al. Systemic injection of neural stem/progenitor cells in mice with chronic EAE. J Vis Exp. 2014; 86: 51154. https://doi.org/10.3791/51154

57. Tsupykov O, Kyryk V, Smozhanik E, et al. Long-term fate of grafted hippocampal neural progenitor cells following ischemic injury. J Neurosci Res. 2014; 92(8): 964-74. https://doi.org/10.1002/jnr.23386 PMid:24753232

58. Gage FH. Stem cells of the central nervous system. Curr Opin Neurobio. 1998; l8(5): 671-76.

59. Skardelly M, Gaber K, Burdack S, et al. Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury. J Neurotrauma. 2011; 28(3): 401-14. https://doi.org/10.1089/neu.2010.1526 PMid:21083415

60. Wennersten A, Meier X, Holmin S, et al. Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J Neurosurg. 2004; 100(1): 88-96. https://doi.org/10.3171/jns.2004.100.1.0088 PMid:14743917

61. Hentze H, Graichen R, Colman A, Hentze H. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol. 2007; 25(1): 24-32. https://doi.org/10.1016/j.tibtech.2006.10.010 PMid:17084475

62. Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010; 5: 121-43. https://doi.org/10.2217/rme.09.74 PMid:20017699 PMCid:PMC2833273

63. Wallenquist U, Brannvall K, Clausen A, et al. Grafted neural progenitors migrate and form neurons after experimental traumatic brain injury. Restor Neurol Neurosci. 2009; 27(4): 323-34. PMid:19738325

64. Tajiri N, Acosta SA, Shahaduzzaman M, et al. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci. 2014; 34(1): 313-26. https://doi.org/10.1523/JNEUROSCI.2425-13.2014 PMid:24381292 PMCid:PMC3866490

65. Walker PA, Shah SK, Hurting MT, et al. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech. 2009; 2(1-2): 23-38. https://doi.org/10.1242/dmm.001198 PMid:19132123 PMCid:PMC2615170

66. Sun D, Gugliotta M, Rolfe A, et al. Sustained survival and maturation of adult neural stem/progenitor cells after transplantation into the injured brain. J Neurotrauma. 2011; 28(6): 961-72. https://doi.org/10.1089/neu.2010.1697 PMid:21332258 PMCid:PMC3113420

67. Barkho BZ, Zhao X. Adult neural stem cells: response to stroke injury and potential for therapeutic applications. Curr Stem Cell Res Ther. 2011; 6(4): 327-38. https://doi.org/10.2174/157488811797904362

68. Yan J, Xu L, Welsh AM, et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med. 2007; 4(2): 39. https://doi.org/10.1371/journal.pmed.0040039 PMid:17298165 PMCid:PMC1796906

69. Sullivan GM, Armstrong RC. Transplanted adult neural stem cells express sonic hedgehog in vivo and suppress white matter neuroinflammation after experimental traumatic brain injury. Stem Cells Int. 2017; doi: 10.1155/2017/9342534. https://doi.org/10.1155/2017/9342534

70. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell stem cell. 2015;17(1): 11-22. https://doi.org/10.1016/j.stem.2015.06.007 PMid:26140604

71. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-76. https://doi.org/10.1016/j.cell.2006.07.024 PMid:16904174

72. Dunkerson J, Moritz KE, Young J, et al. Combining enriched environment and induced pluripotent stem cell therapy results in improved cognitive and motor function following traumatic brain injury. Restor Neurol Neurosci. 2014; 32(5): 675-87. PMid:25079980

73. Cary WA, Hori CN, Pham MT, et al. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells from Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery. World Neurosurg. 2015; 84(5): 1256-1266. https://doi.org/10.1016/j.wneu.2015.05.076 PMid:26074438

74. Kobayashi Y, Okada Y, Itakura G. et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One. 2012; 7(12): 52787. https://doi.org/10.1371/journal.pone.0052787 PMid:23300777 PMCid:PMC3531369

75. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nature. 2010; 465(7299):704-12. https://doi.org/10.1038/nature09229 PMid:20535199 PMCid:PMC2901154

76. Chang CP, Chio CC, Cheong CU, et al. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond). 2013; 124(3): 165-76. https://doi.org/10.1042/CS20120226 PMid:22876972

77. Nardi NB, da Silva Meirelles. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol. 2006; 174: 249-82. https://doi.org/10.1007/3-540-31265-X_11

78. Gutierrez-Fernandez M, Rodriguez-Frutos B, Ramos-Cejudo J, et al. Effects of intravenous administration of allogenic bone marrow and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 2013; 4(1): 11. https://doi.org/10.1186/scrt159 PMid:23356495 PMCid:PMC3706777

79. Mahmood A, Lu D, Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma. 2004; 21(1): 33-9. https://doi.org/10.1089/089771504772695922 PMid:14987463

80. Shi W, Huang CJ, Xu XD, et al. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury. Acta Biomaterialia. 2016; 45: 247-261. https://doi.org/10.1016/j.actbio.2016.09.001 PMid:27592818

81. Mahmood A, Lu D, Lu M, et al. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery. 2003; 53(3): 697-703. https://doi.org/10.1227/01.NEU.0000079333.61863.AA PMid:12943585

82. Wang Z, Luo Y, Chen L, et al. Safety of neural stem cell transplantation in patients with severe traumatic brain injury. Exp Ther Med. 2017; 13(6):3613-18. https://doi.org/10.3892/etm.2017.4423

Цитувати

Chayka AV, Zaben’ko YY, Labunets IF, Pivneva TA. Traumatic brain injury: pathogenesis, experimental models, prospects of cell-based therapy. Cell and Organ Transplantology. 2017; 5(2):209-215. doi:10.22494/cot.v5i2.78

Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.